$Aytu BioPharma (AYTU.US)$Revenue has been growing for the p...

$Aytu BioPharma (AYTU.US)$Revenue has been growing for the past 5 years, while operating profit and net income losses have continued to expand. In the first two quarters of 2023, revenue continued to grow, and operating profit and net income losses narrowed significantly. It is advisable to observe for a few more quarters before making a determination.